Report cover image

Global Brain Health Products Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 194 Pages
SKU # APRC20359914

Description

Summary

According to APO Research, the global Brain Health Products market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Brain Health Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.

The Asia-Pacific market for Brain Health Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Brain Health Products market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.

The Europe market for Brain Health Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Brain Health Products market include Yuwangpharma, Velnex Medicare, Unilever Global, Synergy CHC, Reckitt Benckiser Group plc., Quincy Bioscience, Ocean Health Pte Ltd., Neuriva and Natural Factors, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.

This report presents an overview of global market for Brain Health Products, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Brain Health Products, also provides the value of main regions and countries. Of the upcoming market potential for Brain Health Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Brain Health Products revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Brain Health Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Brain Health Products company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Brain Health Products Segment by Company

Yuwangpharma
Velnex Medicare
Unilever Global
Synergy CHC
Reckitt Benckiser Group plc.
Quincy Bioscience
Ocean Health Pte Ltd.
Neuriva
Natural Factors
Natrol, LLC.
Lifelab Manufacturing
GNC Holdings, LLC
DSM-Firmenich
BL Bio Lab
AdvaCare Pharma
Brain Health Products Segment by Type

Plant Extracts
Fatty Acids
Vitamins
Others
Brain Health Products Segment by Application

Online Sales
Offline Sales
Brain Health Products Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Brain Health Products status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Brain Health Products key companies, revenue, market share, and recent developments.
3. To split the Brain Health Products breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Brain Health Products market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Brain Health Products significant trends, drivers, influence factors in global and regions.
6. To analyze Brain Health Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brain Health Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Brain Health Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brain Health Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Brain Health Products industry.
Chapter 3: Detailed analysis of Brain Health Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Brain Health Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Brain Health Products in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.

Table of Contents

194 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Brain Health Products Market Size, 2020 VS 2024 VS 2031
1.3 Global Brain Health Products Market Size (2020-2031)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Brain Health Products Market Dynamics
2.1 Brain Health Products Industry Trends
2.2 Brain Health Products Industry Drivers
2.3 Brain Health Products Industry Opportunities and Challenges
2.4 Brain Health Products Industry Restraints
3 Brain Health Products Market by Company
3.1 Global Brain Health Products Company Revenue Ranking in 2024
3.2 Global Brain Health Products Revenue by Company (2020-2025)
3.3 Global Brain Health Products Company Ranking (2023-2025)
3.4 Global Brain Health Products Company Manufacturing Base and Headquarters
3.5 Global Brain Health Products Company Product Type and Application
3.6 Global Brain Health Products Company Establishment Date
3.7 Market Competitive Analysis
3.7.1 Global Brain Health Products Market Concentration Ratio (CR5 and HHI)
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.7.3 2024 Brain Health Products Tier 1, Tier 2, and Tier 3 Companies
3.8 Mergers and Acquisitions Expansion
4 Brain Health Products Market by Type
4.1 Brain Health Products Type Introduction
4.1.1 Plant Extracts
4.1.2 Fatty Acids
4.1.3 Vitamins
4.1.4 Others
4.2 Global Brain Health Products Sales Value by Type
4.2.1 Global Brain Health Products Sales Value by Type (2020 VS 2024 VS 2031)
4.2.2 Global Brain Health Products Sales Value by Type (2020-2031)
4.2.3 Global Brain Health Products Sales Value Share by Type (2020-2031)
5 Brain Health Products Market by Application
5.1 Brain Health Products Application Introduction
5.1.1 Online Sales
5.1.2 Offline Sales
5.2 Global Brain Health Products Sales Value by Application
5.2.1 Global Brain Health Products Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global Brain Health Products Sales Value by Application (2020-2031)
5.2.3 Global Brain Health Products Sales Value Share by Application (2020-2031)
6 Brain Health Products Regional Value Analysis
6.1 Global Brain Health Products Sales Value by Region: 2020 VS 2024 VS 2031
6.2 Global Brain Health Products Sales Value by Region (2020-2031)
6.2.1 Global Brain Health Products Sales Value by Region: 2020-2025
6.2.2 Global Brain Health Products Sales Value by Region (2026-2031)
6.3 North America
6.3.1 North America Brain Health Products Sales Value (2020-2031)
6.3.2 North America Brain Health Products Sales Value Share by Country, 2024 VS 2031
6.4 Europe
6.4.1 Europe Brain Health Products Sales Value (2020-2031)
6.4.2 Europe Brain Health Products Sales Value Share by Country, 2024 VS 2031
6.5 Asia-Pacific
6.5.1 Asia-Pacific Brain Health Products Sales Value (2020-2031)
6.5.2 Asia-Pacific Brain Health Products Sales Value Share by Country, 2024 VS 2031
6.6 South America
6.6.1 South America Brain Health Products Sales Value (2020-2031)
6.6.2 South America Brain Health Products Sales Value Share by Country, 2024 VS 2031
6.7 Middle East & Africa
6.7.1 Middle East & Africa Brain Health Products Sales Value (2020-2031)
6.7.2 Middle East & Africa Brain Health Products Sales Value Share by Country, 2024 VS 2031
7 Brain Health Products Country-level Value Analysis
7.1 Global Brain Health Products Sales Value by Country: 2020 VS 2024 VS 2031
7.2 Global Brain Health Products Sales Value by Country (2020-2031)
7.2.1 Global Brain Health Products Sales Value by Country (2020-2025)
7.2.2 Global Brain Health Products Sales Value by Country (2026-2031)
7.3 USA
7.3.1 USA Brain Health Products Sales Value Growth Rate (2020-2031)
7.3.2 USA Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.3.3 USA Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.4 Canada
7.4.1 Canada Brain Health Products Sales Value Growth Rate (2020-2031)
7.4.2 Canada Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.4.3 Canada Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.5 Mexico
7.5.1 Mexico Brain Health Products Sales Value Growth Rate (2020-2031)
7.5.2 Mexico Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.5.3 Mexico Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.6 Germany
7.6.1 Germany Brain Health Products Sales Value Growth Rate (2020-2031)
7.6.2 Germany Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.6.3 Germany Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.7 France
7.7.1 France Brain Health Products Sales Value Growth Rate (2020-2031)
7.7.2 France Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.7.3 France Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.8 U.K.
7.8.1 U.K. Brain Health Products Sales Value Growth Rate (2020-2031)
7.8.2 U.K. Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.8.3 U.K. Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.9 Italy
7.9.1 Italy Brain Health Products Sales Value Growth Rate (2020-2031)
7.9.2 Italy Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.9.3 Italy Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.10 Spain
7.10.1 Spain Brain Health Products Sales Value Growth Rate (2020-2031)
7.10.2 Spain Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.10.3 Spain Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.11 Russia
7.11.1 Russia Brain Health Products Sales Value Growth Rate (2020-2031)
7.11.2 Russia Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.11.3 Russia Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.12 Netherlands
7.12.1 Netherlands Brain Health Products Sales Value Growth Rate (2020-2031)
7.12.2 Netherlands Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.12.3 Netherlands Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.13 Nordic Countries
7.13.1 Nordic Countries Brain Health Products Sales Value Growth Rate (2020-2031)
7.13.2 Nordic Countries Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.13.3 Nordic Countries Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.14 China
7.14.1 China Brain Health Products Sales Value Growth Rate (2020-2031)
7.14.2 China Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.14.3 China Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.15 Japan
7.15.1 Japan Brain Health Products Sales Value Growth Rate (2020-2031)
7.15.2 Japan Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.15.3 Japan Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.16 South Korea
7.16.1 South Korea Brain Health Products Sales Value Growth Rate (2020-2031)
7.16.2 South Korea Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.16.3 South Korea Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.17 India
7.17.1 India Brain Health Products Sales Value Growth Rate (2020-2031)
7.17.2 India Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.17.3 India Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.18 Australia
7.18.1 Australia Brain Health Products Sales Value Growth Rate (2020-2031)
7.18.2 Australia Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.18.3 Australia Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.19 Southeast Asia
7.19.1 Southeast Asia Brain Health Products Sales Value Growth Rate (2020-2031)
7.19.2 Southeast Asia Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.19.3 Southeast Asia Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.20 Brazil
7.20.1 Brazil Brain Health Products Sales Value Growth Rate (2020-2031)
7.20.2 Brazil Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.20.3 Brazil Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.21 Argentina
7.21.1 Argentina Brain Health Products Sales Value Growth Rate (2020-2031)
7.21.2 Argentina Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.21.3 Argentina Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.22 Chile
7.22.1 Chile Brain Health Products Sales Value Growth Rate (2020-2031)
7.22.2 Chile Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.22.3 Chile Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.23 Colombia
7.23.1 Colombia Brain Health Products Sales Value Growth Rate (2020-2031)
7.23.2 Colombia Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.23.3 Colombia Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.24 Peru
7.24.1 Peru Brain Health Products Sales Value Growth Rate (2020-2031)
7.24.2 Peru Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.24.3 Peru Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.25 Saudi Arabia
7.25.1 Saudi Arabia Brain Health Products Sales Value Growth Rate (2020-2031)
7.25.2 Saudi Arabia Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.25.3 Saudi Arabia Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.26 Israel
7.26.1 Israel Brain Health Products Sales Value Growth Rate (2020-2031)
7.26.2 Israel Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.26.3 Israel Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.27 UAE
7.27.1 UAE Brain Health Products Sales Value Growth Rate (2020-2031)
7.27.2 UAE Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.27.3 UAE Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.28 Turkey
7.28.1 Turkey Brain Health Products Sales Value Growth Rate (2020-2031)
7.28.2 Turkey Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.28.3 Turkey Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.29 Iran
7.29.1 Iran Brain Health Products Sales Value Growth Rate (2020-2031)
7.29.2 Iran Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.29.3 Iran Brain Health Products Sales Value Share by Application, 2024 VS 2031
7.30 Egypt
7.30.1 Egypt Brain Health Products Sales Value Growth Rate (2020-2031)
7.30.2 Egypt Brain Health Products Sales Value Share by Type, 2024 VS 2031
7.30.3 Egypt Brain Health Products Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Yuwangpharma
8.1.1 Yuwangpharma Comapny Information
8.1.2 Yuwangpharma Business Overview
8.1.3 Yuwangpharma Brain Health Products Revenue and Gross Margin (2020-2025)
8.1.4 Yuwangpharma Brain Health Products Product Portfolio
8.1.5 Yuwangpharma Recent Developments
8.2 Velnex Medicare
8.2.1 Velnex Medicare Comapny Information
8.2.2 Velnex Medicare Business Overview
8.2.3 Velnex Medicare Brain Health Products Revenue and Gross Margin (2020-2025)
8.2.4 Velnex Medicare Brain Health Products Product Portfolio
8.2.5 Velnex Medicare Recent Developments
8.3 Unilever Global
8.3.1 Unilever Global Comapny Information
8.3.2 Unilever Global Business Overview
8.3.3 Unilever Global Brain Health Products Revenue and Gross Margin (2020-2025)
8.3.4 Unilever Global Brain Health Products Product Portfolio
8.3.5 Unilever Global Recent Developments
8.4 Synergy CHC
8.4.1 Synergy CHC Comapny Information
8.4.2 Synergy CHC Business Overview
8.4.3 Synergy CHC Brain Health Products Revenue and Gross Margin (2020-2025)
8.4.4 Synergy CHC Brain Health Products Product Portfolio
8.4.5 Synergy CHC Recent Developments
8.5 Reckitt Benckiser Group plc.
8.5.1 Reckitt Benckiser Group plc. Comapny Information
8.5.2 Reckitt Benckiser Group plc. Business Overview
8.5.3 Reckitt Benckiser Group plc. Brain Health Products Revenue and Gross Margin (2020-2025)
8.5.4 Reckitt Benckiser Group plc. Brain Health Products Product Portfolio
8.5.5 Reckitt Benckiser Group plc. Recent Developments
8.6 Quincy Bioscience
8.6.1 Quincy Bioscience Comapny Information
8.6.2 Quincy Bioscience Business Overview
8.6.3 Quincy Bioscience Brain Health Products Revenue and Gross Margin (2020-2025)
8.6.4 Quincy Bioscience Brain Health Products Product Portfolio
8.6.5 Quincy Bioscience Recent Developments
8.7 Ocean Health Pte Ltd.
8.7.1 Ocean Health Pte Ltd. Comapny Information
8.7.2 Ocean Health Pte Ltd. Business Overview
8.7.3 Ocean Health Pte Ltd. Brain Health Products Revenue and Gross Margin (2020-2025)
8.7.4 Ocean Health Pte Ltd. Brain Health Products Product Portfolio
8.7.5 Ocean Health Pte Ltd. Recent Developments
8.8 Neuriva
8.8.1 Neuriva Comapny Information
8.8.2 Neuriva Business Overview
8.8.3 Neuriva Brain Health Products Revenue and Gross Margin (2020-2025)
8.8.4 Neuriva Brain Health Products Product Portfolio
8.8.5 Neuriva Recent Developments
8.9 Natural Factors
8.9.1 Natural Factors Comapny Information
8.9.2 Natural Factors Business Overview
8.9.3 Natural Factors Brain Health Products Revenue and Gross Margin (2020-2025)
8.9.4 Natural Factors Brain Health Products Product Portfolio
8.9.5 Natural Factors Recent Developments
8.10 Natrol, LLC.
8.10.1 Natrol, LLC. Comapny Information
8.10.2 Natrol, LLC. Business Overview
8.10.3 Natrol, LLC. Brain Health Products Revenue and Gross Margin (2020-2025)
8.10.4 Natrol, LLC. Brain Health Products Product Portfolio
8.10.5 Natrol, LLC. Recent Developments
8.11 Lifelab Manufacturing
8.11.1 Lifelab Manufacturing Comapny Information
8.11.2 Lifelab Manufacturing Business Overview
8.11.3 Lifelab Manufacturing Brain Health Products Revenue and Gross Margin (2020-2025)
8.11.4 Lifelab Manufacturing Brain Health Products Product Portfolio
8.11.5 Lifelab Manufacturing Recent Developments
8.12 GNC Holdings, LLC
8.12.1 GNC Holdings, LLC Comapny Information
8.12.2 GNC Holdings, LLC Business Overview
8.12.3 GNC Holdings, LLC Brain Health Products Revenue and Gross Margin (2020-2025)
8.12.4 GNC Holdings, LLC Brain Health Products Product Portfolio
8.12.5 GNC Holdings, LLC Recent Developments
8.13 DSM-Firmenich
8.13.1 DSM-Firmenich Comapny Information
8.13.2 DSM-Firmenich Business Overview
8.13.3 DSM-Firmenich Brain Health Products Revenue and Gross Margin (2020-2025)
8.13.4 DSM-Firmenich Brain Health Products Product Portfolio
8.13.5 DSM-Firmenich Recent Developments
8.14 BL Bio Lab
8.14.1 BL Bio Lab Comapny Information
8.14.2 BL Bio Lab Business Overview
8.14.3 BL Bio Lab Brain Health Products Revenue and Gross Margin (2020-2025)
8.14.4 BL Bio Lab Brain Health Products Product Portfolio
8.14.5 BL Bio Lab Recent Developments
8.15 AdvaCare Pharma
8.15.1 AdvaCare Pharma Comapny Information
8.15.2 AdvaCare Pharma Business Overview
8.15.3 AdvaCare Pharma Brain Health Products Revenue and Gross Margin (2020-2025)
8.15.4 AdvaCare Pharma Brain Health Products Product Portfolio
8.15.5 AdvaCare Pharma Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.